These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12140133)

  • 1. The role of colony stimulating factors in small cell lung cancer: why the question is still unsolved.
    Trillet-Lenoir V; Piedbois P; Buyse M
    Lung Cancer; 2002 Aug; 37(2):125-6. PubMed ID: 12140133
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose intensity in small cell lung cancer.
    Thatcher N; Lee SM; Woll PJ; Middleton M; Anderson H; Burt P; Stout R
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):12-8; discussion 45-8. PubMed ID: 9578057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is more better? Chemotherapy for patients with extensive-stage small-cell lung cancer.
    Johnson BE
    J Natl Cancer Inst; 2001 Feb; 93(4):254-5. PubMed ID: 11181764
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis.
    Berghmans T; Paesmans M; Lafitte JJ; Mascaux C; Meert AP; Sculier JP
    Lung Cancer; 2002 Aug; 37(2):115-23. PubMed ID: 12140132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hematopoietic growth factors in small cell lung cancer: a review.
    Trillet-Lenoir VN
    Cancer Treat Res; 1995; 72():273-92. PubMed ID: 7535555
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in chemotherapy for lung cancer.
    Saijo N; Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):54-8. PubMed ID: 7512277
    [No Abstract]   [Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor in the treatment of small cell lung cancer.
    Wolf M; Klausmann M; Havemann K
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):51-6. PubMed ID: 7801147
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose intensification of chemotherapy and the role of granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor in small cell lung cancer.
    Tjan-Heijnen VC; Postmus PE; Wagener DJ
    Anticancer Drugs; 1997 Jul; 8(6):549-64. PubMed ID: 9300569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate.
    Rosell R; Gómez-Codina J; Anton A; Sánchez JJ; Vadell C
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):48-53. PubMed ID: 8153657
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant granulocyte colony stimulating factor in the treatment of small cell lung cancer: a long-term follow-up.
    Trillet-Lenoir V; Green JA; Manegold C; Von Pawel J; Gatzemeier U; Lebeau B; Depierre A; Johnson P; Decoster G; Matcham J
    Eur J Cancer; 1995 Nov; 31A(12):2115-6. PubMed ID: 8562177
    [No Abstract]   [Full Text] [Related]  

  • 11. Increasing the dose intensity of chemotherapy by means of granulocyte-colony stimulating factor (G-CSF) support in the treatment of small cell lung cancer (SCLC).
    Girling DJ; Thatcher N; Clark PI; Stephens RJ
    Eur J Cancer; 1996 Jun; 32A(7):1263. PubMed ID: 8758266
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of leukomax for potentiating combined chemotherapy of small cell lung cancer].
    Gorbunova VA; Bychkov MB; Perevodchikova NI; Orel NF; Smirnova NB
    Vopr Onkol; 1995; 41(1):72-4. PubMed ID: 7667948
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of GM-CSF as adjunctive therapy in small cell lung cancer. Presentation of the interim analysis of a large phase II trial.
    Pujol JL; Tabah I; Michel FB
    Pathol Biol (Paris); 1992 Nov; 39(9):960. PubMed ID: 1311449
    [No Abstract]   [Full Text] [Related]  

  • 14. [Small cell lung cancer: value of G-CSF].
    Trillet V
    Pathol Biol (Paris); 1993 Jan; 41(1):46. PubMed ID: 7686284
    [No Abstract]   [Full Text] [Related]  

  • 15. Filgrastim--human granulocyte-colony stimulating factor.
    Drug Ther Bull; 1993 Apr; 31(9):33-6. PubMed ID: 7688277
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.
    Gridelli C; Perrone F; D'Aprile M; Rossi A; Palmeri S; Curcio C; Veltri E; Ianniello G; Lorusso V; Palmieri G
    Eur J Cancer; 1995 Dec; 31A(13-14):2424-6. PubMed ID: 8652288
    [No Abstract]   [Full Text] [Related]  

  • 17. The availability of granulocyte colony stimulating factor.
    Black P
    N Z Med J; 1994 Apr; 107(976):161-2. PubMed ID: 7513075
    [No Abstract]   [Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords.
    Wilson RF; Henry TD
    J Am Coll Cardiol; 2005 Nov; 46(9):1649-50. PubMed ID: 16256863
    [No Abstract]   [Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).
    Lieschke GJ; Burgess AW
    N Engl J Med; 1992 Jul; 327(2):99-106. PubMed ID: 1376442
    [No Abstract]   [Full Text] [Related]  

  • 20. G-CSF reduces incidence of chemotherapy-associated infections.
    Oncology (Williston Park); 1990 Aug; 4(8):12. PubMed ID: 1698430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.